Global Health Ltd files investor presentation reporting Q2 FY27 revenue of ₹1,469 crore, up 33.6% year on year
- Operating EBITDA was ₹370.1 crore, with a 25.2% margin; EBITDA rose 60.2% year on year.
- Net profit increased 38.3% year on year to ₹219.1 crore.
- Analyst and investor meetings are scheduled for November 16, 17, 19 and 20, 2026.
- Q2 FY26 PBT included ₹16 crore of exceptional income.
